【摘 要】
：
Enhanced external counterpulsation (EECP) has recently emerged as a treatment option for angina in selected patients suitable for revascularization with percutaneous coronary intervention (PCI).We com
【出 处】
：
中国老年学会体外反搏与心血管康复论坛暨第二届国际体外反搏学术交流会
论文部分内容阅读
Enhanced external counterpulsation (EECP) has recently emerged as a treatment option for angina in selected patients suitable for revascularization with percutaneous coronary intervention (PCI).We compared baseline characteristics and l-year outcome in 2 cohorts of PCI candidates presenting with stable symptoms:323 patients treated with EECP in the International EECP Patient Registry (IEPR),and 448 NHLBI Dynamic Registry patients treated with elective PCI.Compared with patients receiving PCI,IEPR patients had a higher prevalence of many risk factors including prior PCl (53.0% vs 33.3%,p <0.001),prior coronary artery bypass grafting (42.1% vs 18.6%,p <0.001),prior myocardial infarction (56.4% vs 27.8%,p <0.001),history of congestive heart failure (16.8% vs 9.2%,p <0.01),and history of diabetes (37.9% vs 23.5%,p <0.001).
其他文献
Data from the International Enhanced External Counterpulsation (EECP) Patient Registry were analyzed To determine which patient characteristics influence improvement in angina class with EECP treatmen
Patients with coronary artery disease have a variety of treatment options available to them.These include medications to control anginal episodes and,when appropriate,revascularization interventions i
EECP is a non-invasive outpatient treatment for cardiovascular disease refractory to medical and/or surgical therapy.It has been cleared by the Food and Drug Administration for the treatment of a vari
The International Enhanced External Counterpulsation (EECP) Patient Registry tracks acute and long-term outcome for consecutive patients treated for chronic angina.Although EECP has previously been sh
Among 2,486 patients enrolled in the International EECP Patient Registry (IEPR) who underwent EECP therapy for symptomatic coronary artery disease,the median diastolic augmentation (DA) ratio increase